ARYA Sciences Acquisition Corp IV

Status: Pre-Deal
IPO Proceeds, $M $149.50M
IPO Date Feb 26, 2021
CEO Adam Stone
Left Lead Goldman Sachs
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Life sciences and medical technology in North America and Europe

IPO Geography Global
Target Company TBD
Deal Announced TBD
Deal Size, $M TBD
Deal Geography TBD
Deal Sector TBD
SEC Filings

Sign up for Free Trial

No credit card required

Sign in for more data on ARYA Sciences Acquisition Corp IV:

  • 7 directors & officers
  • 4 filings and events
  • 2 underwriters
  • 61 shareholders (from 13F filings)